00000nam 2200000zi 4500 9.883880 CaOODSP 20221107170714 m o d f cr |n||||||||| 200123e19770916oncd||| o f00| 0|eng d CaOODSP eng rda CaOODSP n-cn--- RG23-130/1977E-PDF Strategy and activity discussion : retail price disclosure of prescription drugs / Bureau of Consumer Affairs. [Ottawa] : [Consumer and Corporate Affairs Canada], September 16, 1977. 1 online resource (1 volume (various pagings)) : charts text txt rdacontent computer c rdamedia online resource cr rdacarrier Digitized edition from print [produced by Innovation, Science and Economic Development Canada]. "Adequate price disclosure, a major ingredient found in all other consumer purchasing decisions, is practically non-existent in the dispensing of prescription drugs and appears to severely restrict consumer choice and free market competition. In May, 1977, Mediaspec Inc. submitted "A Report on Prescription Drug Price Disclosure" commissioned by the Bureau of Consumer Affairs exploring this issue, and Consumer Services Branch, in collaboration with Consumer Research Branch, was asked to evaluate the findings and conceive a complete strategy for Bureau action. Based on our evaluation and investigation, and with the concurrence of Consumer Research Branch, this paper proposes what we believe to be the most desirable course of action for the Bureau"--Introduction. Drugs Prices Canada. Médicaments Prix Canada. Canada. Bureau of Consumer Affairs, issuing body. PDF 790 KB https://publications.gc.ca/collections/collection_2021/isde-ised/RG23-130-1977-eng.pdf